Viking Therapeutics Skyrockets On Obesity Drug Data. Lilly Rises, But Novo Falls.
Viking stock catapulted Tuesday on "stellar" test results for its weight-loss shot, sending Novo down.
- Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall. · investors.com · 1 day ago